Fox Run Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39,983	Closed	-$598K	–	873
2025 Q3	$598K	Buy	39,983 +19,788	+98%	+$241K	0.09%	418
2025 Q2	$235K	Sell	20,195 -1,370	-6%	-$12.4K	0.04%	712
2025 Q1	$160K	Buy	21,565 +1,631	+8%	+$12.5K	0.02%	822
2024 Q4	$120K	Buy	+19,934	New	+$110K	0.02%	795
2023 Q3	–	Sell	-21,724	Closed	-$146K	–	674
2023 Q2	$146K	Buy	21,724 +1,375	+7%	+$10.2K	0.04%	616
2023 Q1	$180K	Buy	20,349 +1,124	+6%	+$9.91K	0.06%	552
2022 Q4	$147K	Buy	+19,225	New	+$150K	0.06%	528
2022 Q2	–	Sell	-14,491	Closed	-$201K	–	498
2022 Q1	$201K	Buy	+14,491	New	+$228K	0.11%	416
2021 Q4	–	Sell	-8,912	Closed	-$303K	–	449
2021 Q3	$303K	Buy	+8,912	New	+$322K	0.19%	226